Phase 3 Study to Evaluate the Lot Consistency of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This Phase 3 study is intended to assess clinical lot-to-lot consistency by evaluating and comparing the immunogenicity of three consecutively manufactured lots of Coronavirus-like Particle (CoVLP).
Epistemonikos ID: c317c448c3a1fbbe4cd9e0f74c2e5216bf351ed9
First added on: Sep 11, 2021